Skip to main content

Advertisement

Log in

Pre-weaning fluoxetine exposure caused anti-depressant like behavior at adulthood via perturbing tryptophan metabolism in rats

  • Original Article
  • Published:
Metabolic Brain Disease Aims and scope Submit manuscript

Abstract

The perinatal depression exposes the child to antidepressants during vulnerable window of development, which can chronically impact the mental wellbeing of new born. Active pharmaceuticals are not tested for this long term neurobehavioral aspect of toxicity during drug development process. Keeping this in view, the current study was designed to study the effect of pre-weaning fluoxetine exposure on depression-like behavior of the offspring upon attaining adulthood using FST (Forced swim test). Additionally, the brain tryptophan, 5-HT (5-hydroxytryptamine) and its metabolite 5-HIAA (5-hydroxyindoleacetic acid) levels were quantified using Enzyme linked Immunosorbent Assay (ELISA), while expression of SERT (serotonin receptor), 5-HT1A receptor, TPH (tryptophan hydroxylase) genes were monitored using qPCR. Our data showed that pre-weaning fluoxetine (10, 50 or 100 mg/kg) exposure decreased depression-like behavior. The 5-HT and 5-HIAA levels showed declining trend. However, the 5-HT synthetic precursor i.e. tryptophan levels were found to be significantly elevated in both brain and plasma as compared to control rats. The gene expression study did not reveal any significant alterations as compared to control. In conclusion, the present study demonstrate that pre-weaning fluoxetine exposure decreased depression-like behavior upon adulthood via perturbing tryptophan metabolism.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Scheme1

Similar content being viewed by others

Data availability

The datasets generated during and/or analysed during the current study are not publicly available due to fact that the study is the part of ongoing research but are available from the corresponding author on reasonable request.

Code availability

Not applicable.

References

  • Abbas G, Naqvi S, Mehmood S, Kabir N, Dar A (2011) Forced swimming stress does not affect monoamine levels and neurodegeneration in rats. Neurosci Bull 27(5):319–324

    Article  CAS  Google Scholar 

  • Abbas G, Naqvi S, Dar A (2012) Comparison of monoamine reuptake inhibitors for the immobility time and serotonin levels in the hippocampus and plasma of sub-chronically forced swim stressed rats. Pak J Pharm Sci 25:441–445

    CAS  PubMed  Google Scholar 

  • Abbott LC, Nigussie F (2020) Adult neurogenesis in the mammalian dentate gyrus. Anat Histol Embryol 49(1):3–16

    Article  Google Scholar 

  • Albert PR, Vahid-Ansari F, Luckhart C (2014) Serotonin-prefrontal cortical circuitry in anxiety and depression phenotypes: pivotal role of pre-and post-synaptic 5-HT1A receptor expression. Front Behav Neurosci 8:199

    Article  Google Scholar 

  • Andersen SL (2003) Trajectories of brain development: point of vulnerability or window of opportunity? Neurosci Biobehav Rev 27(1–2):3–18

    Article  Google Scholar 

  • Atif M, Halaki M, Raynes-Greenow C, Chow CM (2021) Perinatal depression in Pakistan: A systematic review and meta-analysis. Birth 48(2):149–163

    Article  Google Scholar 

  • Bach-Mizrachi H, Underwood MD, Kassir SA, Bakalian MJ, Sibille E, Tamir H, Mann JJ, Arango V (2006) Neuronal tryptophan hydroxylase mRNA expression in the human dorsal and median raphe nuclei: major depression and suicide. Neuropsychopharmacology 31(4):814–824

    Article  CAS  Google Scholar 

  • Chambers CD, Hernandez-Diaz S, Van Marter LJ, Werler MM, Louik C, Jones KL, Mitchell AA (2006) Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med 354(6):579–587

    Article  CAS  Google Scholar 

  • Cipriani A, Brambilla P, Furukawa TA, Geddes J, Gregis M, Hotopf M, Malvini L, Barbui C (2005) Fluoxetine versus other types of pharmacotherapy for depression. Cochrane Database Syst Rev (4):CD004185

  • Cooper WO, Willy ME, Pont SJ, Ray WA (2007) Increasing use of antidepressants in pregnancy. Am J Obstet Gynecol 196(6):544. e541-544. e545

    Article  Google Scholar 

  • de Oliveira CL, Bolzan JA, Surget A, Belzung C (2020) Do antidepressants promote neurogenesis in adult hippocampus? A systematic review and meta-analysis on naive rodents. Pharmacol Ther 210:107515

    Article  Google Scholar 

  • Gaynes BN, Gavin N, Meltzer-Brody S, Lohr KN, Swinson T, Gartlehner G, Brody S, Miller WC (2005) Perinatal depression: prevalence, screening accuracy, and screening outcomes: summary. AHRQ Evid Rep Summ 119:1–35

    Google Scholar 

  • Gronemann FH, Petersen J, Alulis S, Jensen KJ, Riise J, Ankarfeldt MZ, Solem EJ, Bødker N, Osler M (2021) Treatment patterns in patients with treatment-resistant depression in Danish patients with major depressive disorder. J Affect Disord 287:204–213

    Article  Google Scholar 

  • Hemels ME, Einarson A, Koren G, Lanctôt KL, Einarson TR (2005) Antidepressant use during pregnancy and the rates of spontaneous abortions: a meta-analysis. Ann Pharmacother 39(5):803–809

    Article  Google Scholar 

  • James SL, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, Abbastabar H, Abd-Allah F, Abdela J, Abdelalim A (2018) Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392(10159):1789–1858

    Article  Google Scholar 

  • Kendall K, Van Assche E, Andlauer T, Choi K, Luykx J, Schulte E, Lu Y (2021) The genetic basis of major depression. Psychol Med 51(13):2217–2230

    Article  CAS  Google Scholar 

  • Klaassen CD, Watkins JB (2010) Casarett & Doull's essentials of toxicology, 3rd Edition, McGraw-Hill Medical Pub. Division

  • Koressaar T, Remm M (2007) Enhancements and modifications of primer design program Primer3. Bioinformatics 23(10):1289–1291

    Article  CAS  Google Scholar 

  • Levone BR, Moloney GM, Cryan JF, O’Leary OF (2021) Specific sub-regions along the longitudinal axis of the hippocampus mediate antidepressant-like behavioral effects. Neurobiol Stress 14:100331

    Article  Google Scholar 

  • Licht T, Kreisel T, Biala Y, Mohan S, Yaari Y, Anisimov A, Alitalo K, Keshet E (2020) Age-dependent remarkable regenerative potential of the dentate gyrus provided by intrinsic stem cells. J Neurosci 40(5):974–995

    Article  Google Scholar 

  • Macedo NJ, Ferreira TL (2014) Maximizing total RNA yield from TRIzol reagent protocol: a feasibility study. ASEE Zone I Conference

  • Mann JJ, McBride PA, Anderson GM, Mieczkowski TA (1992) Platelet and whole blood serotonin content in depressed inpatients: correlations with acute and life-time psychopathology. Biol Psychiat 32(3):243–257

    Article  CAS  Google Scholar 

  • Millard SJ, Lum JS, Fernandez F, Weston-Green K, Newell KA (2019) Perinatal exposure to fluoxetine increases anxiety-and depressive-like behaviours and alters glutamatergic markers in the prefrontal cortex and hippocampus of male adolescent rats: A comparison between Sprague-Dawley rats and the Wistar-Kyoto rat model of depression. J Psychopharmacol 33(2):230–243

    Article  CAS  Google Scholar 

  • Mirowsky J (1996) Age and the gender gap in depression. J Health Soc Behav 37:362–380

    Article  CAS  Google Scholar 

  • Mirowsky J, Ross CE (1992) Age and depression. J Health Soc Behav 33(3):187–205

    Article  CAS  Google Scholar 

  • Nadeem, Siddiqui RA, Usman S, Nisar U, Abbas G (2021) Pre-weaning fluoxetine exposure perturbs social behavior at adulthood via altering hippocampal morphometry and PSD-95 expression in rats. Pak J Pharm Sci 34:795–802

    CAS  PubMed  Google Scholar 

  • Nikolac Perkovic M, Sagud M, Tudor L, Konjevod M, Svob Strac D, Pivac N (2021) A load to find clinically useful biomarkers for depression. Major depressive disorder, Springer 1305:175–202

  • Owens MJ (2004) Selectivity of antidepressants: from the monoamine hypothesis of depression to the SSRI revolution and beyond. J Clin Psychiatry 65:5–10

    CAS  PubMed  Google Scholar 

  • Porsolt RD, Le Pichon M, Jalfre M (1977) Depression: a new animal model sensitive to antidepressant treatments. Nature 266(5604):730–732

    Article  CAS  Google Scholar 

  • Ramsteijn AS, Jašarević E, Houwing DJ, Bale TL, Olivier JD (2020) Antidepressant treatment with fluoxetine during pregnancy and lactation modulates the gut microbiome and metabolome in a rat model relevant to depression. Gut Microbes 11(4):735–753

    Article  Google Scholar 

  • Rosa-Neto P, Diksic M, Okazawa H, Leyton M, Ghadirian N, Mzengeza S, Nakai A, Debonnel G, Blier P, Benkelfat C (2004) Measurement of brain regional α-[11C] Methyl-L-tryptophan trapping as a measure of serotonin synthesis in medication-freepatients with major depression. Arch Gen Psychiatry 61(6):556–563

    Article  CAS  Google Scholar 

  • Rossi A, Barraco A, Donda P (2004) Fluoxetine: a review on evidence based medicine. Ann Gen Hosp Psychiatry 3(1):1–8

    Article  Google Scholar 

  • Roth W, Zadeh K, Vekariya R, Ge Y, Mohamadzadeh M (2021) Tryptophan metabolism and gut-brain homeostasis. Int J Mol Sci 22(6):2973

    Article  CAS  Google Scholar 

  • Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative C T method. Nat Protoc 3(6):1101

    Article  CAS  Google Scholar 

  • Shi M, Sun H, Xu Y, Wang Z, Cui H, Wang C, Liu W, An G, Hu J (2017) Methylation status of the serotonin transporter promoter CpG island is associated with major depressive disorder in Chinese Han population: a case-control study. J Nerv Ment Dis 205(8):641–646

    Article  Google Scholar 

  • Ulbrich B, Palmer AK (1996) Neurobehavioral aspects of developmental toxicity testing. Environ Health Perspect 104(suppl 2):407–412

    Article  CAS  Google Scholar 

  • Untergasser A, Cutcutache I, Koressaar T, Ye J, Faircloth BC, Remm M, Rozen SG (2012) Primer3—new capabilities and interfaces. Nucleic Acids Res 40(15):e115–e115

    Article  CAS  Google Scholar 

  • WHO (2012) Risks to mental health: An overview of vulnerabilities and risk factors. Geneva, Switzerland pp 1–14

  • Więdłocha M, Marcinowicz P, Janoska-Jaździk M, Szulc A (2021) Gut microbiota, kynurenine pathway and mental disorders–Review. Prog Neuro-Psychopharmacol Biol Psychiatry 106:110145

    Article  Google Scholar 

  • Zaman N, Ahmad H, Ali Abid M, Roome T, Abbas G (2017) Acetaminophen (paracetamol) facilitated extinction lear ning in contextual fear conditioned rats. Lett Drug Des Discovery 14(8):898–903

    Article  CAS  Google Scholar 

  • Zavvari F, Nahavandi A, Goudarzi M (2020) Fluoxetine attenuates stress-induced depressive-like behavior through modulation of hippocampal GAP43 and neurogenesis in male rats. J Chem Neuroanat 103:101711

    Article  Google Scholar 

  • Zhang X, Gainetdinov RR, Beaulieu J-M, Sotnikova TD, Burch LH, Williams RB, Schwartz DA, Krishnan KRR, Caron MG (2005) Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron 45(1):11–16

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

Following are the author’s contribution in the submitted work: All experiments were performed by Nadeem. The gene expression and ELISA work was assisted by Shumaila Usman, Irfan Khan and Rehan Imad. The data presentation and statistical analysis was helped by Uzair Nisar. Entire word was conceptualized and supervised by Ghulam Abbas. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Ghulam Abbas.

Ethics declarations

Ethics approval

This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of University (Approval No. 2019–004).

Consent to participate

Not applicable.

Consent for publication

Not applicable.

Conflicts of interest / Competing interests

The authors have no relevant financial or non-financial interests to disclose.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nadeem, Usman, S., Imad, R. et al. Pre-weaning fluoxetine exposure caused anti-depressant like behavior at adulthood via perturbing tryptophan metabolism in rats. Metab Brain Dis 37, 1415–1422 (2022). https://doi.org/10.1007/s11011-022-00951-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11011-022-00951-4

Keywords

Navigation